MARKET INSIGHT: US neurostim market set to grow by $1bn+ with new indications, new technologies
This article was originally published in Clinica
Executive Summary
The US neurostimulation technology market will grow about 46% over the next five years, driven by the introduction of more effective implantable neurostimulation devices and increasing awareness and acceptance of these technologies among patients and physicians, according to a new report from Medtech Insight.